DaVita Inc.
Last updated September 27, 2026
Organization details
- Legal name
- DaVita Inc.
- Former names
- Davita Healthcare Partners INC. Total Renal Care Holdings Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 8090 — Services-Misc Health & Allied Services, NEC
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Denver
- Headquarters state / province
- Colorado
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DVA
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000927066
- EIN
- 51-0354549
Board of directors
-
Adam H. Schechter · DirectorSince 2023
-
Barbara J. Desoer · DirectorSince 2023
-
Charles Berg · DirectorSince 2023
-
Dennis W. Pullin · DirectorSince 2024
-
Gregory J. Moore · DirectorSince 2023
-
Jason M. Hollar · DirectorSince 2023
-
Javier Rodriguez · Director · Chief Executive OfficerSince 2023
-
John M. Nehra · DirectorSince 2023
-
Pamela M. Arway · DirectorSince 2023
-
Paul J. Diaz · DirectorSince 2023
-
Phyllis R. Yale · DirectorSince 2023
-
Wendy Lee Schoppert · DirectorSince 2023
Chief executives
Javier Rodriguez
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.7%
-
99.4%
-
99.4%
-
99.4%
-
99.7%
-
99.8%
-
99.9%
-
99.9%
-
99.9%
Board connections
8 of this board's directors also sit on 11 other boards.
- via Pamela M. Arway and Wendy Lee Schoppert
- via Phyllis R. Yale
- via Paul J. Diaz
- via Barbara J. Desoer
- via Gregory J. Moore
- via Wendy Lee Schoppert
- via Javier Rodriguez
- via Pamela M. Arway
- via Adam H. Schechter
- via Paul J. Diaz
- via Wendy Lee Schoppert
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $508,681,065
- 13 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Maughan David Paul Officer (Chief Operating Officer, DKC) | Shares withheld for tax | −7,501 | $182.34 | $1,367,732 |
| Aug 15, 2026 | Pamela M. Arway Director | Grant or award | +278 | — | — |
| Aug 15, 2026 | Phyllis R. Yale Director | Grant or award | +278 | — | — |
| Aug 15, 2026 | Wendy Lee Schoppert Director | Grant or award | +278 | — | — |
| Aug 15, 2026 | Dennis W. Pullin Director | Grant or award | +278 | — | — |
| Aug 15, 2026 | Gregory J. Moore Director | Grant or award | +278 | — | — |
| Aug 15, 2026 | Adam H. Schechter Director | Grant or award | +278 | — | — |
| Aug 15, 2026 | Barbara J. Desoer Director | Grant or award | +278 | — | — |
| Aug 15, 2026 | Jason M. Hollar Director | Grant or award | +278 | — | — |
| Jul 31, 2026 | BERKSHIRE HATHAWAY INC 10% owner | Open-market sale | −182,980 | $199.55 | $36,513,293 |
| Jun 16, 2026 | Javier Rodriguez Director, Officer (Chief Executive Officer) | Open-market sale | −39,407 | $209.28 | $8,247,097 |
| Jun 15, 2026 | Waters Kathleen Alyce Officer (Chief Legal & Pub. Affairs Off) | Open-market sale | −8,950 | $207.84 | $1,860,168 |
| Jun 15, 2026 | Javier Rodriguez Director, Officer (Chief Executive Officer) | Open-market sale | −30,000 | $209.50 | $6,285,000 |
| Jun 15, 2026 | Waters Kathleen Alyce Officer (Chief Legal & Pub. Affairs Off) | Open-market sale | −6,455 | $209.17 | $1,350,192 |
| May 26, 2026 | Phyllis R. Yale Director | Gift | −5,038 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.